Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass RTS,S/AS01 vaccination to the integrated malaria...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Main Authors: von Seidlein, Lorenz, Hanboonkunupakarn, Borimas, Jittamala, Podjanee, Pongsuwan, Pongphaya, Chotivanich, Kesinee, Tarning, Joel, Hoglund, Richard M., Winterberg, Markus, Mukaka, Mavuto, Peerawaranun, Pimnara, Sirithiranont, Pasathorn, Doran, Zoe, Ockenhouse, Christian F., Ivinson, Karen, Lee, Cynthia, Birkett, Ashley J., Kaslow, David C., Singhasivanon, Pratap, Day, Nicholas P.J., Dondorp, Arjen M., White, Nicholas J., Pukrittayakamee, Sasithon
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012096/
https://ncbi.nlm.nih.gov/pubmed/31306084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1643675
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares